Fundraising FoxCreator Fund — 2024 Investments
4 investments dated 2024 · listed companies and verified rows first · show all
Biophoundry develops phage-based technologies for therapeutics, diagnostics, and bio-molecular engineering, including its Phax platform aimed at making phage therapy faster and more affordable.
AI & Machine LearningBiotechHealthtechChapel Hill, US
Rani Brooks(CEO & Co-Founder)inSahan B.W. Liyanagedera(Executive Officer, Director)
BoardLouis Marlow(Director)
Didimi builds interoperability solutions for the construction industry, aimed at helping construction projects manage data exchange and reduce wasted time and cost.
Construction TechSaaSLondon, GB
Alex Gillies(Founder)inKyriakos Kantarakias(Founder)in
Co-investorsGenesis VenturesPlug and Play Ventures
Fairgen builds AI and machine learning tools that generate synthetic survey respondents to extend and scale market research data.
AI & Machine LearningData & InfrastructureMarketing TechSaaSTel Aviv, IL
Benny Schnaider(Chairman)inSamuel Cohen(CEO & Co-founder)inMichael Cohen(COO)in
BoardEmmanuel Candès(Scientific Lead Advisor)
Co-investorsIGNIAMaverick Ventures IsraelTal Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Myria Biosciences
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.